Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses

PS Sullivan, AS Johnson, ES Pembleton… - The Lancet, 2021 - thelancet.com
The HIV epidemic in the USA began as a bicoastal epidemic focused in large cities but, over
nearly four decades, the epidemiology of HIV has changed. Public health surveillance data …

Pre-exposure prophylaxis (PrEP) for HIV infection in cisgender and transgender women in the US: a narrative review of the literature

A Baldwin, B Light, WE Allison - Archives of sexual behavior, 2021 - Springer
Using a socioecological approach, this review describes the peer-reviewed literature on oral
pre-exposure prophylaxis (PrEP) among both cisgender (cis women) and transgender …

Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week …

O Ogbuagu, PJ Ruane, D Podzamczer, LC Salazar… - The Lancet …, 2021 - thelancet.com
Background In DISCOVER, a multinational, randomised controlled trial, emtricitabine and
tenofovir alafenamide compared with emtricitabine and tenofovir disoproxil fumarate …

A longitudinal, qualitative exploration of perceived HIV risk, healthcare experiences, and social support as facilitators and barriers to PrEP adoption among Black …

LA Nydegger, J Dickson-Gomez, T Ko Ko - AIDS and Behavior, 2021 - Springer
Black women contract HIV at much higher rates than White or Hispanic women. Pre-
exposure prophylaxis (PrEP) is an underutilized prevention tool among this population. We …

Providers PrEP: identifying primary health care providers' biases as barriers to provision of equitable PrEP services

SJ Hull, H Tessema, J Thuku… - JAIDS Journal of Acquired …, 2021 - journals.lww.com
Background: Despite their disparately high HIV incidence and voiced willingness to use pre-
exposure prophylaxis (PrEP), Black cisgender women's knowledge and uptake of PrEP are …

“PrEP's just to secure you like insurance”: a qualitative study on HIV pre-exposure prophylaxis (PrEP) adherence and retention among black cisgender women in …

TC Willie, M Monger, A Nunn, T Kershaw… - BMC infectious …, 2021 - Springer
Abstract Background Pre-exposure prophylaxis (PrEP) has the potential to reduce
transmission of HIV among Black cisgender women in the Southern United States (US); …

Call to action: how can the US Ending the HIV Epidemic initiative succeed?

C Beyrer, AA Adimora, SL Hodder, E Hopkins, G Millett… - The Lancet, 2021 - thelancet.com
With more than 1· 2 million people living with HIV in the USA, a complex epidemic across the
large and diverse country, and a fragmented health-care system marked by widening health …

Interest in long-acting injectable pre-exposure prophylaxis (LAI PrEP) among women in the Women's Interagency HIV Study (WIHS): a qualitative study across six …

MM Philbin, C Parish, EN Kinnard, SE Reed… - AIDS and Behavior, 2021 - Springer
Long-acting injectable (LAI) pre-exposure prophylaxis (PrEP) has the potential to facilitate
adherence and transform HIV prevention. However, little LAI PrEP research has occurred …

A qualitative exploration of women's interest in long-acting injectable antiretroviral therapy across six cities in the women's interagency HIV study: intersections with …

MM Philbin, C Parish, S Bergen, D Kerrigan… - AIDS patient care and …, 2021 - liebertpub.com
Medications for antiretroviral therapy (ART) and preexposure prophylaxis (PrEP) are
currently daily pill regimens, which pose barriers to long-term adherence. Long-acting …

Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi …

A Belludi, AM McFall, SS Solomon, DD Celentano… - PloS one, 2021 - journals.plos.org
Introduction Pre-exposure prophylaxis (PrEP) is effective in reducing HIV transmission
among key populations. In India, where PrEP is not currently part of the national HIV …